Benitec Biopharma (BNTC) Income Statement: Revenue & Earnings

Benitec Biopharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Benitec Biopharma Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.08	0.07	0.06	0.10
Cost of Revenue	0.40	-0.11	0.00	0.01	0.12	0.00
Gross Profit	-0.40	0.11	0.08	0.06	0.06	0.10
Operating Expenses
Research & Development	18.33	15.61	12.77	11.27	7.02	3.00
Selling, General & Administrative	23.43	6.99	6.38	6.65	6.51	5.57
Operating Expenses	41.37	22.49	19.16	17.92	13.66	8.38
Operating Income	-41.77	-22.49	-19.08	-17.85	-13.60	-8.28
Other Income/Expense
Interest Income	3.29	0.90	0.00	0.00	0.00	0.00
Interest Expense	0.00	0.00	-0.03	0.03	-0.01	0.00
Other Income/Expense	3.85	0.21	-0.03	-0.32	-0.05	-0.04
Income
Income Before Tax	-37.92	-22.48	-19.56	-18.21	-13.64	-8.64
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	-37.92	-21.75	-19.56	-18.21	-13.88	-8.27
Net Income - Continuous Operations	-37.92	-21.75	-19.56	-18.21	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-41.70	-21.41	-18.95	-17.78	-13.21	-8.27
EBIT	-41.77	-21.75	-19.08	-18.18	-13.64	-8.64
Depreciation & Amortization	0.07	0.09	0.14	0.17	0.23	0.19
Earnings Per Share
Basic EPS	-1.00	-6.00	-14.00	-38.00	-55.00	-138.00
Diluted EPS	-1.00	-6.00	-14.00	-38.00	-55.00	-138.00
Basic Shares Outstanding	36.21	4.06	1.39	0.48	0.25	0.06
Diluted Shares Outstanding	36.21	4.06	1.39	0.48	0.25	0.06